How much influence should patients have in drug approval recommendations?
This article was originally published in Scrip
Executive Summary
Just how far should patients be involved in decision-making processes regarding new drug evaluations? It's a question that the European Medicines Agency is poring over as it looks at how best to match regulatory science to clinical needs, based partly on the views of those who are on the receiving end of innovation in medicine.